The world population is suffering a lot of genetic diseases. These diseases have been very hard to tackle so far. Fortunately, since a few decades viral vectors and gene therapies became more and more ...

Paul Cashen is a Senior Bioprocess Specialist at Pall, where he works on the downstream purification and analysis of viral vectors, monoclonal antibodies and recombinant proteins. From this experience ...